Avance Biosciences Inc.

Our mission is to assist our customers in advancing biological drug development. Our goal is to be the number one choice of vendors for high quality biologic assay services. Our leading scientists, in their careers, have successfully designed and executed several hundred studies under the strict GLP/GMP regulations of the US FDA, European and Japanese regulatory agencies. Avance Biosciences™ offers DNA sequencing, quantitative PCR (qPCR), and molecular biology services in compliance with the regulations of US FDA (cGMP/GLP), European, and Japanese regulatory agencies. We also provide non-regulated services, including next generation sequencing, to academic and industrial researchers. The Avance Biosciences™ team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, Japanese, and other international regulatory agencies. Our expertise in real-time PCR, digital droplet PCR (ddPCR), next-generation sequencing (NGS), and many other molecular biology, cell biology, and microbiology tools enable us to provide testing solutions that bolster our clients’ CGT programs. Avance Biosciences™ is a leading provider of biologics safety testing for both eukaryotic and prokaryotic development projects, offering Sanger sequencing, next generation DNA sequencing, real-time PCR, digital PCR, Southern blot, northern blot and other molecular biology and microbiology methods to support our clients’ biological drug development and manufacturing needs.